Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma
出版年份 2022 全文链接
标题
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma
作者
关键词
-
出版物
NATURE MEDICINE
Volume 28, Issue 9, Pages 1848-1859
出版商
Springer Science and Business Media LLC
发表日期
2022-09-13
DOI
10.1038/s41591-022-01959-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Decade-long leukaemia remissions with persistence of CD4+ CAR T cells
- (2022) J. Joseph Melenhorst et al. NATURE
- Phenotypic composition of commercial anti-CD19 CAR-T cells affects in vivo expansion and disease response in large B-cell lymphoma patients
- (2022) Chiara Monfrini et al. CLINICAL CANCER RESEARCH
- Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL
- (2022) Aimee Talleur et al. Blood Advances
- Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming
- (2021) Yao Wang et al. Nature Communications
- Tumor interferon signaling and suppressive myeloid cells associate with CAR T cell failure in large B cell lymphoma
- (2021) Michael D. Jain et al. BLOOD
- CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel
- (2021) Vicki Plaks et al. BLOOD
- BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells
- (2021) Hyungseok Seo et al. NATURE IMMUNOLOGY
- A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains
- (2021) Kathryn M. Cappell et al. Nature Reviews Clinical Oncology
- scCODA is a Bayesian model for compositional single-cell data analysis
- (2021) M. Büttner et al. Nature Communications
- Confronting false discoveries in single-cell differential expression
- (2021) Jordan W. Squair et al. Nature Communications
- Impaired death receptor signaling in leukemia causes antigen-independent resistance by inducing CAR T cell dysfunction
- (2020) Nathan Singh et al. Cancer Discovery
- Regulatory T-cell depletion in the setting of autologous stem cell transplantation for multiple myeloma: pilot study
- (2020) Benjamin A Derman et al. Journal for ImmunoTherapy of Cancer
- Chimeric antigen receptor signaling: Functional consequences and design implications
- (2020) S. E. Lindner et al. Science Advances
- A Review of Two Regulatory Approved Anti-CD19 CAR T-Cell Therapies in Diffuse Large B-Cell Lymphoma: Why Are Indirect Treatment Comparisons Not Feasible?
- (2020) Jie Zhang et al. ADVANCES IN THERAPY
- A Distinct Transcriptional Program in Human CAR T Cells Bearing the 4-1BB Signaling Domain Revealed by scRNA-Seq
- (2020) Angela C. Boroughs et al. MOLECULAR THERAPY
- Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B cell malignancies
- (2020) Jordan Gauthier et al. BLOOD
- Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
- (2020) Jeremy S Abramson et al. LANCET
- Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas
- (2020) Qing Deng et al. NATURE MEDICINE
- Naive T cell deficits at diagnosis and after chemotherapy impair cell therapy potential in pediatric cancers
- (2019) Rajat K Das et al. Cancer Discovery
- Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
- (2019) Yosuke Togashi et al. Nature Reviews Clinical Oncology
- ZBP1 mediates interferon-induced necroptosis
- (2019) Daowei Yang et al. Cellular & Molecular Immunology
- Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data
- (2019) Samuel L. Wolock et al. Cell Systems
- TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
- (2019) Omar Khan et al. NATURE
- SLAMF6 as a Regulator of Exhausted CD8+ T Cells in Cancer
- (2019) Burcu Yigit et al. Cancer Immunology Research
- Fast, sensitive and accurate integration of single-cell data with Harmony
- (2019) Ilya Korsunsky et al. NATURE METHODS
- Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity
- (2019) Olli Dufva et al. BLOOD
- Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
- (2018) Joseph A. Fraietta et al. NATURE MEDICINE
- Cell banking for regulatory T cell-based therapy: strategies to overcome the impact of cryopreservation on the Treg viability and phenotype
- (2018) Karolina Gołąb et al. Oncotarget
- Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
- (2018) Elena J. Orlando et al. NATURE MEDICINE
- Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function
- (2018) Alexander I. Salter et al. Science Signaling
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Defining Memory CD8 T Cell
- (2018) Matthew D. Martin et al. Frontiers in Immunology
- Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
- (2017) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Life and Death of Activated T Cells: How Are They Different from Naïve T Cells?
- (2017) Yifan Zhan et al. Frontiers in Immunology
- A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation
- (2016) Satoru Todo et al. HEPATOLOGY
- Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
- (2016) I. Tirosh et al. SCIENCE
- Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells
- (2015) Zeguo Zhao et al. CANCER CELL
- Cish actively silences TCR signaling in CD8 + T cells to maintain tumor tolerance
- (2015) Douglas C. Palmer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Freeze and Thaw of CD4+CD25+Foxp3+ Regulatory T Cells Results in Loss of CD62L Expression and a Reduced Capacity to Protect against Graft-versus-Host Disease
- (2015) Mareike Florek et al. PLoS One
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Challenges in cryopreservation of regulatory T cells (Tregs) for clinical therapeutic applications
- (2013) Karolina Golab et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Dynamics extracted from fixed cells reveal feedback linking cell growth to cell cycle
- (2013) Ran Kafri et al. NATURE
- Response Criteria in Oncologic Imaging: Review of Traditional and New Criteria
- (2013) Temel Tirkes et al. RADIOGRAPHICS
- In vivo Inhibition of Human CD19-Targeted Effector T Cells by Natural T Regulatory Cells in a Xenotransplant Murine Model of B Cell Malignancy
- (2011) J. C. Lee et al. CANCER RESEARCH
- Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen Receptor
- (2009) James N. Kochenderfer et al. JOURNAL OF IMMUNOTHERAPY
- Regulatory T Cells and Immune Tolerance
- (2008) Shimon Sakaguchi et al. CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started